These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5801961)

  • 1. [Efficacy of ajmalin (gylurritmal) in the treatment of a paroxysmal auricular fibrillation lasting for 3 weeks in a case of W.P.W].
    Duclós F
    Rev Esp Cardiol; 1969; 22(2):240-54. PubMed ID: 5801961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability].
    Bossi M; Botti G; Campus S; Cardini A; Cherchi A; Coljca A; Di Benedetto A; Folli G; Franzosi P; Geraci E; Lampertico M; Lotto A; Magnani B; Modica G; Selvini A; Serio G; Visioli O
    Minerva Med; 1970 Jan; 61(5):113-20. PubMed ID: 4189651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Di-mono-chloracetyl-ajmaline in the treatment of cardiac rhythm disorders].
    Bucour V; Enesco R; Sirbulesco R; Pompilian P
    Minerva Med; 1970 Jan; 61(5):128-35. PubMed ID: 4189652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
    Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P
    Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases].
    Poveda Sierra J; Pajarón A; Medrano GA
    Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

  • 7. [3 years of experience with treatment of some arrhythmias with Ritmos (ajmaline)].
    Apostolov L; Batalov Z; Mironov P; Panitsa D
    Minerva Med; 1970 Jan; 61(5):121-7. PubMed ID: 5412616
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of DCAA (Ritmos Elle) in hospital practice in grave arrhythmias].
    De Michelis S; Paparella P; Seu V
    Minerva Med; 1970 Jan; 61(5):136-49. PubMed ID: 4189653
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial fibrillation in the Wolff-Parkinson-White syndrome: effects of verapamil and procainamide.
    Laufer N; Crevey B
    Ariz Med; 1985 Mar; 42(3):150-3. PubMed ID: 3994532
    [No Abstract]   [Full Text] [Related]  

  • 11. How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
    Connolly S
    Can J Cardiol; 1994 Apr; 10(3):330. PubMed ID: 8162530
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atrial fibrillation and Wolff-Parkinson-White syndrome. The hidden danger of manifested pathways].
    Cruz Filho FE
    Arq Bras Cardiol; 1995 Feb; 64(2):97-100. PubMed ID: 7575169
    [No Abstract]   [Full Text] [Related]  

  • 13. The limitations of anti-arrhythmic drug therapy.
    Shimomura K; Ohe T
    Jpn Circ J; 1983 Jan; 47(1):153-7. PubMed ID: 6827772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paroxysmal auricular fibrillation and Wolff-Parkinson-White syndrome].
    Laham J
    Coeur Med Interne; 1972; 11(1):97-108. PubMed ID: 5014856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of the association of acetyldigitoxin and disopyramide in the attack treatment of complete tachyarrhythmia due to auricular fibrillation].
    Lambert B
    Mars Med; 1971; 108(12):851-3. PubMed ID: 5145502
    [No Abstract]   [Full Text] [Related]  

  • 16. Broad complex atrial fibrillation.
    Chew HC; Lim SH
    Am J Emerg Med; 2007 May; 25(4):459-63. PubMed ID: 17499667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of atrial fibrillation--Part 2.
    Aronow WS
    Compr Ther; 2008; 34(3-4):134-42. PubMed ID: 19137754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observations on the effects of di-monochloracetyl-ajmaline].
    Sperandeo V; Di Benedetto A; Mendola R
    Minerva Med; 1970 Jan; 61(5):150-6. PubMed ID: 4189654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].
    Velázquez Rodríguez E; Cancino Rodríguez C; Arias Estrada S; Rangel Rojo J; Hernández Morales E; Uribe Muñoz A
    Arch Inst Cardiol Mex; 2000; 70(2):160-6. PubMed ID: 10932801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.